Overview

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of graft pretreatment with CGT003 (E2F Duplex Decoy), as compared to placebo, on the incidence of patients experiencing vein graft failure after coronary artery bypass surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Anesiva, Inc.